Francesca Porcellati

4.2k citations

75 papers · 2.8k indexed · 1 hit paper · h-index 28

Endocrinology, Diabetes and Metabolism top 0.5%
Surgery top 2%
Genetics top 2%
Molecular Biology
Physiology top 10%

Co-authors: Carmine G. Fanelli Geremia B. Bolli Simone Pampanelli Paolo Rossetti Mauro Lepore Paola Lucidi P. Brunetti Luca Bartocci
Topics: Diabetes Management and Research (54 papers)Diabetes Treatment and Management (35 papers)Pancreatic function and diabetes (35 papers)
Cited by: Endocrinology, Diabetes and Metabolism Surgery Genetics
Journals: Journal of Clinical Investigation Annals of Internal Medicine The Journal of Clinical Endocrinology & Metabolism
Partner nations: Italy United Kingdom United States

In The Last Decade

Francesca Porcellati

71 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

2000 617 citations Simone Pampanelli, Carmine G. Fanelli et al. Diabetes profile →

Peers

Countries citing papers authored by Francesca Porcellati

Since Specialization

Citations

This map shows the geographic impact of Francesca Porcellati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Porcellati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Porcellati more than expected).

Fields of papers citing papers by Francesca Porcellati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Porcellati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Porcellati. The network helps show where Francesca Porcellati may publish in the future.

Co-authorship network of co-authors of Francesca Porcellati

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Porcellati. A scholar is included among the top collaborators of Francesca Porcellati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Porcellati. Francesca Porcellati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A new role for glucagon: from secondary hormone to key player 2025 ·Nutrition Metabolism and Cardiovascular Diseases ·(unknown),(unknown),(unknown),Melania Manco,Carmine G. Fanelli,Geremia B. Bolli,Francesca Porcellati	0
2	The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes 2025 ·Diabetes Care ·Geremia B. Bolli,Philip Home,Francesca Porcellati,Matthew C. Riddle,Hertzel C. Gerstein,Paola Lucidi,Carmine G. Fanelli,David R. Owens	3
3	An overview of randomized clinical trials of fixed‐ratio combinations of basal insulin plus GLP ‐ 1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes 2025 ·Diabetes Obesity and Metabolism ·Geremia B. Bolli,Francesca Porcellati,Paola Lucidi,Carmine G. Fanelli,Gianluca Perseghin,Michael Horowitz,David R. Owens	1
4	The Sweet Side of Constipation: Colonic Motor Dysfunction in Diabetes Mellitus 2025 ·Nutrients ·(unknown),(unknown),Megan Manco,Francesca Porcellati,Carmine G. Fanelli,Gabrio Bassotti	0
5	The impact of ideglira in treatment simplification in older adults with type 2 diabetes mellitus already on insulin therapy: The stop study 2025 ·Diabetes Research and Clinical Practice ·(unknown),(unknown),Carmine G. Fanelli,(unknown),Dionysios P. Xenos,Virginia Boccardi,Francesca Porcellati	3
6	Management of Diabetes Mellitus in Acromegaly and Cushing’s Disease with Focus on Pasireotide Therapy: A Narrative Review 2024 ·Diabetes Metabolic Syndrome and Obesity ·(unknown),Alberto Falorni,(unknown),Francesca Porcellati,Carmine G. Fanelli	1
7	Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage 2023 ·Diabetes ·Paola Lucidi,G. Perriello,Francesca Porcellati,Simone Pampanelli,(unknown),Andrea Tura,Geremia B. Bolli,Carmine G. Fanelli	2
8	Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy 2023 ·Diabetes Therapy ·(unknown),(unknown),Felice Strollo,Angelina Passaro,Salvatore Greco,Marcello Monesi,Renato Bigoni,Francesca Porcellati,Daniela Piani,Ersilia Satta,Sandro Gentile	2
9	Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin? 2021 ·Biomolecules ·Francesca Porcellati,Stefania Di Mauro,(unknown),Alessandra Scamporrino,Agnese Filippello,(unknown),Carmine G. Fanelli,Francesco Purrello,Roberta Malaguarnera,Salvatore Piro	6
10	Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL−1 and Insulin Degludec 100 units · mL−1 in Type 1 Diabetes 2020 ·Diabetes Care ·Paola Lucidi,Paola Candeloro,Patrizia Cioli,Anna Marinelli Andreoli,Chiara Pascucci,Angela Gambelunghe,Geremia B. Bolli,Carmine G. Fanelli,Francesca Porcellati	18
11	Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 2019 ·Diabetes Technology & Therapeutics ·Paola Lucidi,Francesca Porcellati,Patrizia Cioli,Paola Candeloro,Anna Marinelli Andreoli,Geremia B. Bolli,Carmine G. Fanelli	8
12	Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study 2018 ·BMC Nephrology ·S. Siméon,Ziad A. Massy,Kurt Højlund,Katarina Lalić,Francesca Porcellati,(unknown),John R. Petrie,Gemma Currie,Beverley Balkau	1
13	Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort 2017 ·Metabolism ·Melania Manco,G. Nolfe,Zoltan Pataky,Lucilla D. Monti,Francesca Porcellati,Rafael Gabriel,Asimina Mitrakou,Geltrude Mingrone	34
14	Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes 2017 ·Diabetes & Metabolism ·Paola Lucidi,Francesca Porcellati,Annalisa Andreoli,Paola Candeloro,Patrizia Cioli,Geremia B. Bolli,Carmine G. Fanelli	3
15	Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH 2017 ·Medicine ·Francesca Porcellati,Jay Lin,Paola Lucidi,Geremia B. Bolli,Carmine G. Fanelli	7
16	Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus 2011 ·Diabetes Care ·Francesca Porcellati,Paola Lucidi,Paolo Rossetti,Paola Candeloro,Anna Marinelli Andreoli,Stefania Marzotti,Patrizia Cioli,Geremia B. Bolli,Carmine G. Fanelli	16
17	Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes 2010 ·Diabetes Obesity and Metabolism ·Geremia B. Bolli,Stephen D. Luzio,Stefania Marzotti,Francesca Porcellati,(unknown),B Charbonnel,Yassine Zaïr,D. R. Owens	30
18	Mechanisms of Insulin Resistance After Insulin-Induced Hypoglycemia in Humans: The Role of Lipolysis 2010 ·Diabetes ·Paola Lucidi,Paolo Rossetti,Francesca Porcellati,Simone Pampanelli,Paola Candeloro,Anna Marinelli Andreoli,G. Perriello,Geremia B. Bolli,Carmine G. Fanelli	36
19	Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double‐blind and cross‐over trial 2005 ·Diabetic Medicine ·G. Perriello,Simone Pampanelli,Francesca Porcellati,Angelo Avogaro,Emanuele Bosi,Giovanna Petrella,Sebastiano Squatrito,(unknown),Giampiero Marra,Letizia Vitali,M. Previti,Domenico Cucinotta	43
20	Better long‐term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal‐time lispro insulin 2004 ·Diabetic Medicine ·Francesca Porcellati,Paolo Rossetti,Simone Pampanelli,Carmine G. Fanelli,Elisabetta Torlone,L. Scionti,G. Perriello,Geremia B. Bolli	109

About Francesca Porcellati

Francesca Porcellati is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics, having authored 75 papers that have together received 2.8k indexed citations. Recurring topics across this work include Diabetes Management and Research (54 papers), Diabetes Treatment and Management (35 papers) and Pancreatic function and diabetes (35 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Surgery (1.5k citations) and Genetics (884 citations). Francesca Porcellati has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Carmine G. Fanelli, Geremia B. Bolli, Simone Pampanelli, Paolo Rossetti, Mauro Lepore, Paola Lucidi, P. Brunetti, Luca Bartocci, Angelo Di Vincenzo and L. Scionti. Their work appears in journals such as Journal of Clinical Investigation, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact